MedTrace Logo

A Diagnostic Study on Patients With Drug-induced Liver Injury

NCT04526548 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-08-27

No results posted yet for this study

Summary

This study is a multi-center, prospective, non-interventional cohort study with an estimated enrollment of 600 patients with acute DILI. According to the inclusion and exclusion criteria, the RUCAM scale and/or expert evaluation, patients with a clinical diagnosis of acute DILI will be included in the study to establish a multi-center, prospective DILI cohort. Depending on the presence or absence of associated chronic liver disease, the patients will be divided into the basic DILI group with chronic liver disease and basic DILI group without chronic liver disease. All enrolled patients should complete at least six months of follow-up.

Conditions

Sponsors & Collaborators

  • Drug Induced Liver Disease Study Group

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-31
Primary Completion
2021-04-30
Completion
2021-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04526548 on ClinicalTrials.gov